← FDA DRUG APPROVALS

FDA ANDA · ANDA062935

PENICILLIN V POTASSIUM

Sponsor: CHARTWELL RX

APPLICATION
ANDA062935
TYPE
ANDA
ORIGINAL APPROVAL
1988-11-23
LATEST ACTION
2025-10-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

PENICILLIN V POTASSIUMPrescription
PENICILLIN V POTASSIUM EQ 500MG BASE · TABLET · ORAL

Approval history

2025-10-31Labeling · Supplement 11 · standardAP
1996-07-09Manufacturing (CMC) · Supplement 6AP
1994-01-06Labeling · Supplement 5AP
1992-12-04Manufacturing (CMC) · Supplement 2AP
1992-12-04Labeling · Supplement 3AP
1992-05-18Manufacturing (CMC) · Supplement 4AP
1989-12-01Manufacturing (CMC) · Supplement 1AP
1988-11-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →